[The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts]
- PMID: 11715458
[The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts]
Abstract
Objective: To evaluate the efficacy of a rapid detoxification schedule for heroin addicts by scopolamine combined with opiate receptor antagonists.
Methods: The life signs such as temperature, blood pressure, ECG, heart rate, respiratory rate and blood oxygen saturation were monitored during the process of rapid detoxification treatment. The naloxone challenge test, withdrawal symptoms scale and naltrexone maintenance were used to evaluate the efficacy of the rapid detoxification.
Results: The withdrawal symptoms of 84 heroin addicts induced by naltrexone and naloxone were controlled completely under scopolamine administration in the 6-8 hours treatment period, although the naloxone challenge test was able to induce slight and transient withdrawal symptoms in the second day, and all patients were transferred rapidly to naltrexone maintenance. During treatment, the temperature in 19 cases elevated, and all patients showed increased heart rate, blood pressure and respiratory rate. However, the blood oxygen saturation was still stable after oral-administration of naltrexone and continuous injection of naloxone during the detoxification. Blood test in gastric fluid was positive in 3 cases during the detoxification. The follow-up data showed that the average maintenance time of naltrexone was 2.6 months, and the percentage of drug free was 21% in 6 months after the detoxification in 84 cases.
Conclusion: The combined use of scopolamine, naltrexone and naloxone is a rapid, safe and effective detoxification treatment protocol for heroin addicts.
Similar articles
-
Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.Acta Anaesthesiol Scand. 2000 Mar;44(3):326-33. doi: 10.1034/j.1399-6576.2000.440319.x. Acta Anaesthesiol Scand. 2000. PMID: 10714849
-
Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone.Clin Pharmacol Ther. 1977 Apr;21(4):409-13. doi: 10.1002/cpt1977214409. Clin Pharmacol Ther. 1977. PMID: 849672
-
Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance.J Subst Abuse Treat. 2000 Mar;18(2):185-91. doi: 10.1016/s0740-5472(99)00050-1. J Subst Abuse Treat. 2000. PMID: 10716102 Clinical Trial.
-
[Forced opioid detoxification under general anesthesia--a new challenge for anesthetists and intensive care physicians].Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 May;34(5):261-8. doi: 10.1055/s-1999-188. Anasthesiol Intensivmed Notfallmed Schmerzther. 1999. PMID: 10372215 Review. German.
-
Anesthesia-assisted rapid opiate detoxification: a new procedure in the postanesthesia care unit.J Perianesth Nurs. 1999 Aug;14(4):207-12; quiz 213-6. doi: 10.1016/s1089-9472(99)80084-7. J Perianesth Nurs. 1999. PMID: 10745790 Review.
Cited by
-
Effects of Brugmansia arborea Extract and Its Secondary Metabolites on Morphine Tolerance and Dependence in Mice.Evid Based Complement Alternat Med. 2012;2012:741925. doi: 10.1155/2012/741925. Epub 2012 Feb 8. Evid Based Complement Alternat Med. 2012. PMID: 22454681 Free PMC article.
-
Scopolamine detoxification technique for heroin dependence: a randomized trial.CNS Drugs. 2013 Dec;27(12):1093-102. doi: 10.1007/s40263-013-0111-9. CNS Drugs. 2013. PMID: 24092568 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical